Nyrada (ASX:NYR) Accounts Payable : A$0.27 Mil (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Nyrada Accounts Payable?

Nyrada's Accounts Payable for the quarter that ended in Dec. 2023 was A$0.27 Mil.

Nyrada's quarterly Accounts Payable declined from Dec. 2022 (A$1.07 Mil) to Jun. 2023 (A$0.51 Mil) and declined from Jun. 2023 (A$0.51 Mil) to Dec. 2023 (A$0.27 Mil).

Nyrada's annual Accounts Payable declined from Jun. 2021 (A$0.59 Mil) to Jun. 2022 (A$0.07 Mil) but then increased from Jun. 2022 (A$0.07 Mil) to Jun. 2023 (A$0.51 Mil).

Nyrada Accounts Payable Historical Data

The historical data trend for Nyrada's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nyrada Accounts Payable Chart

Nyrada Annual Data

Trend

Jun19

Jun20

Jun21

Jun22

Jun23

Accounts Payable

0.28

0.21

0.59

0.07

0.51

Nyrada Semi-Annual Data
	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Payable	Get a 7-Day Free Trial			0.39	0.07	1.07	0.51	0.27

Nyrada Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Nyrada Accounts Payable Related Terms

Thank you for viewing the detailed overview of Nyrada's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Nyrada (ASX:NYR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nyrada Inc (ASX:NYR) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

828 Pacific Highway, Suite 2, Level 3, Gordon, NSW, AUS, 2072

Website

https://www.nyrada.com

Nyrada Inc is a preclinical-stage, drug discovery, and development company, specializing in novel small-molecule drugs to treat cardiovascular and neurological diseases. The company's two programs center on cholesterol-lowering and brain injury, each targeting market sectors of notable size and unmet clinical needs. The programs are focused on developing an oral, small molecule cholesterol-lowering drug, and a drug to treat secondary brain damage following a stroke or traumatic brain injury.

Nyrada (ASX:NYR) Headlines

No Headlines